Explore the best data analytics tools for enterprises in 2026 that harness AI and advanced analytics to improve data-driven decision-making. Uncover key features, pricing, and ideal use cases to boost ...
Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...
The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results